Appendix 2.1 Contents of New Listing Application
Cross-referenced from Rule 246(1)
Brief Particulars
The following information must be provided in the listing application:—
Note: Application should be made to list only that part of the share capital, which has been issued, shares to be issued in connection with the new listing application, and shares to be issued pursuant to Part VIII of Chapter 8.
Appendix 2.2 Articles of Association
Cross referenced from Rules 210(7), 211(5), 246(3) and 409(2)
Every member shall be entitled to receive share certificates in reasonable denominations for his holding and where a charge is made for certificates, such charge shall not exceed two dollars.
The repayment of preference capital other than redeemable preference capital, or any alteration of preference shareholders' rights, may only be made pursuant to a special resolution of the preference shareholders concerned, provided always that where the necessary majority for such a special resolution is not obtained at the meeting, consent in writing if obtained from the holders of three-fourths of the preference shares concerned within two months of the meeting, shall be as valid and effectual as a special resolution carried at the meeting.
The scope of the borrowing powers of the board of directors shall be expressed.
The notices convening meetings shall specify the place, day and hour of the meeting, and shall be given to all shareholders at least fourteen days before the meeting (excluding the date of notice and the date of meeting). Where notices contain special resolutions, they must be given to shareholders at least twenty-one days before the meeting (excluding the date of notice and the date of meeting). Any notice of a meeting called to consider special business shall be accompanied by a statement regarding the effect of any proposed resolutions in respect of such businesses. At least fourteen days' notice of every such meeting shall be given by advertisement in the daily press and in writing to each stock exchange on which the company is listed.
An issuer must hold its annual general meeting within four months from the end of its financial year.
The basis on which shareholders would participate in a distribution of assets on a winding up shall be expressed.
Amended on 7 February 20207 February 2020.
Appendix 2.3.1 Undertaking in Support of Primary Listing Application for Debt Securities* / Equities* / Investment Funds*
Crossed-referenced from Rules 212(3), 248(1), 315(1), 410(1)
* Delete where applicable
To: Singapore Exchange Securities Trading Limited
We, ........................................................................... ("the Applicant "),
(Name of Applicant )
in consideration of Singapore Exchange Securities Trading Limited ("SGX-ST") granting our application for admission to the Official List (where applicable, specify Main Board or Catalist) and quotation of our securities agree:—
The above Undertaking has been signed by me as ....................................
(title)
Signed pursuant to authority granted to me by resolution of the Board of Directors of the said corporation on ...........................................
............................... | |
Name | |
.............................. | .......................... |
Signature | Date |
Amended on 29 September 201129 September 2011.
Appendix 2.3.2 Undertaking in Support of Secondary Listing Application for Equities* / Investment Funds*
Crossed-referenced from Rule 248(1)
* Delete where applicable
To: Singapore Exchange Securities Trading Limited
We, ..................................................................................... ("the Applicant" )
(Name of Applicant)
in consideration of Singapore Exchange Securities Trading Limited ("SGX-ST") granting our application for admission to the Official List and quotation of our securities agree:—
The above Undertaking has been signed by me as ....................................................
(title)
Signed pursuant to authority granted to me by resolution of the Board of Directors of the said corporation on ..........................................
............................... | |
Name | |
.............................. | .......................... |
Signature | Date |
Amended on 29 September 201129 September 2011 and 3 November 20143 November 2014.
Appendix 7.1 Corporate Disclosure Policy
Cross-referenced from Rule 703(4)
Part I Introduction
Part II Issuers' Obligations Under Rule 703
Under Rule 703, the following events, while not comprising a complete list of all the situations which may require disclosure, are likely to require immediate disclosure:—
Part III Exception to Rule 703
Condition 1: A reasonable person would not expect the information to be disclosed
Condition 2: The information is confidential
Generally, information may be regarded as confidential if the issuer has control of the use that can be made of the information. Confidentiality also means that no one in possession of the information is entitled to trade in that issuer's listed securities. In this regard, unusual activity in the issuer's securities may suggest that the information is no longer confidential. If so, this condition is not met. (See also "Confidentiality")
Condition 3: The information is of the type in one of the listed categories.
If the information is not of the type in one of the listed categories, or if it loses that character, then the condition is not satisfied.
Part IV Examples of the Operation of Rule 703
In the course of a successful negotiation for the acquisition of another company, for example, the only information known to each party at the outset may be the willingness of the other to hold discussions. Shortly thereafter, it may become apparent to the parties that it is likely an agreement can be reached. Finally, agreement in-principle may be reached on specific terms. In such circumstances, an issuer need not issue a public announcement at each stage of the negotiations, describing the current state of constantly changing facts but may await agreement in-principle on specific terms. If, on the other hand, progress in the negotiations should stabilise at some other point, disclosure should then be made if the information is material.
Disclosure of an issuer's internal estimates or projections of its earnings or of other data relating to its affairs is not necessary. If such estimates or projections are released, they should be prepared carefully, be soundly based and should be realistic. The estimates or projections should be qualified, if necessary, to ensure that they are properly understood. Should subsequent developments indicate that performance will not match earlier estimates or projections, this too should be reported promptly and the variances adequately explained.
Part V Confidentiality
Part VI Clarification or Confirmation of Rumours or Reports
Part VII Unusual Trading Activity
Part VIII Policy on Thorough Public Dissemination
Part IX Content and Preparation of Public Announcement
Part X Policy on Insider Trading
Part XI Role of Market Surveillance
Amended on 7 February 20207 February 2020, 7 February 20207 February 2020 and 12 February 2021.
Appendix 7.2 Financial Statements and Dividend Announcement
Cross-referenced from Rule 705
Part I Information Required for Quarterly (Q1, Q2 & Q3), Half-Year and Full Year Announcements
Part II Additional Information Required for Full Year Announcement
Latest Financial Year $'000 | Previous Financial Year $'000 | % increase/ (decrease) | |
Group | Group | Group | |
(a) Sales reported for first half year | | ||
(b) Operating profit/loss after tax before deducting non-controlling interests reported for first half year | | ||
(c) Sales reported for second half year | | ||
(d) Operating profit/loss after tax before deducting non-controlling interests reported for second half year | |
Name | Age | Family relationship with any director and/or substantial shareholder | Current position and duties, and the year the position was held | Details of changes in duties and position held, if any, during the year |
Amended on 29 September 201129 September 2011, 7 October 20157 October 2015, 31 March 201731 March 2017, 1 January 20191 January 2019, 7 February 20207 February 2020 and 7 February 20207 February 2020.
Appendix 7.4.1 Announcement of Appointment
Cross-referenced from Rule 210(5)(d) and Rule 704(7)
Date of Appointment
Date of last re-appointment (if applicable)
Name of person
Age
Country of principal residence
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process).
Whether appointment is executive, and if so, the area of responsibility
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Professional qualifications
Working experience and occupation(s) during the past 10 years
Shareholding interest in the listed issuer and its subsidiaries
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Conflict of interest (including any competing business)
Undertaking (in the format set out in Appendix 7.7) under Rule 720(1) has been submitted to the listed issuer Yes No
Other Principal Commitments* Including Directorships#
* "Principal Commitments" has the same meaning as defined in the Code.
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9)
Past (for the last 5 years)
Present
Information required
Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is "yes", full details must be given.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner? | Yes | No | |
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency? | Yes | No | |
(c) Whether there is any unsatisfied judgment against him? | Yes | No | |
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose? | Yes | No | |
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach? | Yes | No | |
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part? | Yes | No | |
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust? | Yes | No | |
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust? | Yes | No | |
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity? | Yes | No | |
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :— | |||
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or | Yes | No | |
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or | Yes | No | |
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or | Yes | No | |
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, | Yes | No | |
in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust? | |||
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere? | Yes | No |
Information required
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange? | Yes | No |
If yes, please provide details of prior experience.
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable).
Amended on 29 September 201129 September 2011, 7 October 20157 October 2015, 1 January 20191 January 2019 and 1 January 2022.
Appendix 7.4.2 Announcement of Cessation
Cross-referenced from Rule 704(7)
Name of person | ||
Age | ||
Is Effective Date of Cessation known? | Yes | No |
If yes, please provide the date. | ||
If no, please advise when the date will be announced. | ||
Detailed Reason(s) for cessation | ||
Are there any unresolved differences in opinion on material matters between the person and the board of directors including matters which would have a material impact on the group or its financial reporting? | Yes | No |
If yes, please elaborate. | ||
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | Yes | No |
If yes, please elaborate. | ||
Any other relevant information to be provided to shareholders of the listed issuer? | ||
If yes, please elaborate. | ||
Date of appointment to current position | ||
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | ||
Role and responsibilities | ||
Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes | No |
Number of Independent Directors currently resident in Singapore (taking into account this cessation). | ||
Do Independent Directors make up at least one-third of the board (taking into account this cessation)? | Yes | No |
Number of cessations of appointments specified in Listing Rule 704(7) over the past 12 months | ||
Shareholding interest in the listed issuer and its subsidiaries | ||
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries | ||
Other Directorships Past (for the last 5 years) Present |
Amended on 29 September 201129 September 2011 and 1 January 20221 January 2022.
Appendix 7.5 Summary of Reserves and Resources
Cross-referenced from Rules 705(7), 1207(21) and Practice Note 6.3
The following information must be provided for each asset of the issuer:
Date of report:
Date of previous report (if applicable):
Name of Asset/Country/Project:
Category | Mineral Type | Gross Attributable to Licence | Net Attributable to Issuer1 | Remarks | |||
Tonnes (millions) | Grade | Tonnes (millions) | Grade | Change from previous update (%) | |||
Reserves | |||||||
Proved | |||||||
Probable | |||||||
Total | |||||||
Resources * | |||||||
Measured | |||||||
Indicated | |||||||
Inferred | |||||||
Total |
* To state whether the Mineral Resources are reported additional to, or inclusive of, the Mineral Reserves.
Name of Asset/Country/Project:
Category | Gross Attributable to Licence (MMbbl / Bcf) | Net Attributable to Issuer1 | Risk Factors2 | Remarks | |
(MMbbl / Bcf) | Change from previous update (%) | ||||
Reserves | |||||
Oil Reserves | |||||
1P | |||||
2P | |||||
3P | |||||
Natural Gas Reserves | |||||
1P | |||||
2P | |||||
3P | |||||
Natural Gas Liquids Reserves | |||||
1P | |||||
2P | |||||
3P | |||||
Contingent Resources | |||||
Oil | |||||
1C | |||||
2C | |||||
3C | |||||
Natural Gas | |||||
1C | |||||
2C | |||||
3C | |||||
Natural Gas Liquids | |||||
1C | |||||
2C | |||||
3C | |||||
Prospective Resources | |||||
Oil | |||||
Low Estimate | |||||
Best Estimate | |||||
High Estimate | |||||
Natural Gas | |||||
Low Estimate | |||||
Best Estimate | |||||
High Estimate |
1P: Proved
2P: Proved + Probable
3P: Proved + Probable + Possible
MMbbl: Millions of barrels
Bcf: Billions of cubic feet
Name of Qualified Person:____________________________________
Date:____________________________________
Professional Society Affiliation / Membership:__________________________________
1 To state reason if this is different from net entitlement to issuer
2 Applicable to Resources. "Risk Factor" for Contingent Resources means the estimated chance, or probability, that the volumes will commercially extracted. "Risk Factor" for Prospective Resources, means the chance or probability of discovering hydrocarbons in sufficient quantity for them to be tested to the surface. This, then, is the chance or probability of the Prospective Resources maturing into a Contingent Resource
Added on 27 September 201327 September 2013 and amended on 23 August 201823 August 2018.
Appendix 7.6 Form of Certification
(Cross-referenced from Rule 751)
To: Singapore Exchange Securities Trading Limited
I, XXX [Full Name (including non-English characters as reflected in identification documents) and Designation) of xxx (the "Company"), an officer duly authorized to give this certification, hereby certify to the Exchange that after making due and careful enquiry, and at the time of this certification, the Company has complied with the applicable continuing listing obligations in the SGX Listing Manual on a continuing basis.
Name:
Designation:
Signature:
Date:
Added on 3 November 20143 November 2014.
Appendix 7.7 Form of Undertaking with Regard to Directors or Executive Officers
Cross-referenced from Rule 250(6) and Rule 720(1)
To: Singapore Exchange Securities Trading Limited
c/o..........(Insert the name of the Issuer/REIT manager/trustee-manager)
In consideration of the listing and quotation of the securities of__________ (insert the name of the issuer) (the "Issuer") on the Official List of the SGX Mainboard:—
(Insert the name of the Issuer/REIT manager/trustee-manager) I, the undersigned, shall:—
Correspondence Address: _____________________
*Please tick accordingly.
Signature: ___________________________________________
Name of director/executive officer: ____________________________________[full name (including non-English characters as reflected in identification documents)]
Nationality:___________________________________________
Singapore NRIC Number:___________________________________________
In case of a non-Singapore NRIC cardholder, state the passport number or any identification number and name of issuing authority:
________________________________________Date: ________________________________________________
Note:
If you have any queries you should consult the Exchange or your professional adviser immediately.
Added on 7 October 20157 October 2015 and amended on 30 April 201630 April 2016.
Appendix 8.1 Contents of Application for Listing Additional Securities
Cross-referenced from Rule 875
1 Title Page
2 Capitalisation
3 Financial Position
4 Acquisitions
Where the issue is to be made as full or partial payment for the acquisition of an interest in, or the business and assets of another company or of any assets or properties, the following information must be provided:—
Note: Additional details may be required to enable the Exchange to have a full understanding of the transaction.
5 Capitalisation Issues
6 Rights Issues
Note: Attention is drawn to Practice Note 8.1 governing the determination of the dates above.
7 Convertible Securities
8 Issue of Shares for Cash Under Part IV of Chapter 8
Amended on 7 February 20207 February 2020.
Appendix 8.2 Disclosure Requirements for Rights Issues or Bought Deals
Cross-referenced from Rules 607, 814(1) and 1015(5)(d)
Either (i) and (ii), or (iii) as applicable:—
A review of the working capital for the last three financial years and the latest half year, if applicable.
A responsibility statement by the financial adviser in the form set out in paragraph 3.1 of Practice Note 12.1.
Amended on 29 September 201129 September 2011 and 7 February 20207 February 2020.
Appendix 8.3.1 Daily Share Buy-Back Notice
Cross-referenced from Rule 886(2)
Maximum number of shares authorised for purchase
1. | Date of Purchases | |
2. | (a) Total number of shares purchased (b) Number of shares cancelled (c) Number of shares held as treasury shares | |
3. | (a) Price paid per share or (b) • Highest price per share • Lowest price per share | |
4. | Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares | |
1. | Date of Purchases | |
2. | (a) Total number of shares purchased (b) Number of shares cancelled (c) Number of shares held as treasury shares | |
3. | Price paid or payable per share | |
4. | Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares | |
By way of market acquisition | By way of off-market acquisition on equal access scheme | Total | ||||
Number | %1 | Number | % | Number | % | |
Cumulative number of shares purchased to date2 | | | | | | |
Number of issued shares excluding treasury shares and subsidiary holdings after purchase | |
Number of treasury shares held after purchase | |
Number of subsidiary holdings after purchase | |
1 Percentage of company's issued shares excluding treasury shares and subsidiary holdings as at the date of the share buy-back resolution.
2 From the date on which the share-buyback mandate is obtained.
Amended on 31 March 201731 March 2017.
Appendix 8.3.2 Daily Share Buy-Back Notice
(for issuers with a dual listing overseas)
Cross-referenced from Rule 886(2)
Name of Overseas Exchange if Company has Dual Listing: ___________________
Maximum number of shares authorised for purchase
Singapore Exchange | Overseas Exchange | ||
1. | Date of Purchases | | |
2. | (a) Total number of shares purchased (b) Number of shares cancelled (c) Number of shares held as treasury shares | ||
3. | (a) Price paid per share or (b) • Highest price per share • Lowest price per share (specify currency) | ||
4. | Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares | | |
Singapore Exchange | Overseas Exchange | ||
1. | Date of Purchases | | |
2. | (a) Total number of shares purchased or agreed to be purchased (b) Number of shares cancelled (c) Number of shares held as treasury shares | ||
3. | Price paid or payable per share (specify currency) | | |
4. | Total consideration (including stamp duties, clearing charges, etc) paid or payable for the shares | | |
By way of market acquisition | By way of off-market acquisition on equal access scheme | Total | ||||
Number | %1 | Number | % | Number | % | |
Cumulative number of shares purchased to date2 | | | | | | |
Number of issued shares excluding treasury shares and subsidiary holdings after purchase | |
Number of treasury shares held after purchase | |
Number of subsidiary holdings after purchase | |
1 Percentage of company's total number of issued shares excluding treasury shares and subsidiary holdings as at the date of the share buy-back resolution.
2 From the date on which the share-buyback mandate is obtained.
Amended on 31 March 201731 March 2017.
Appendix 8.4.1 Application for Listing of Securities Arising from Exercise of Company Warrants/Convertible Preference Shares* Primary/Secondary* Listing
Cross-referenced from Rules 870(2) and 880
Name of Applicant:
__________________________________________________________
Application for listing of _______________________________________________ additional securities of $ ___________ each fully paid arising from the exercise of ______________ Company Warrants/Convertible Preference Shares*.
(If they do not rank pari passu, confirm that the new certificates have been endorsed accordingly, and provide a specimen copy of the endorsed certificate to the Exchange)
Class of security : ______________________
Total number of issued shares excluding treasury shares | Company Warrants/Convertible Preference Shares* | ||||
Number | $ | Number | $ | ||
Before exercise Add: Issued pursuant to exercise | Before exercise Less: Amount exercised | ||||
After exercise | | | Amount outstanding | | |
$ ____________ (if more than one issue, give a breakdown)
Outstanding Options: ____________________ shares/stock units*
Name: | Authorised Signature: |
________________________ | _______________ |
Designation: | Date: |
_________________ | _______________ |
Enclosures:
Note: (a) and (b) are not applicable to secondary listing applications.
(d) is not applicable to primary listing applications.
* Delete where applicable.
Appendix 8.4.2 Application for Listing of Securities Arising from Convertible Loan Stocks/Bonds* — Primary/Secondary* Listing
Cross-referenced from Rules 870(2) and 880
Name of Applicant: __________________________________________________________
Application for listing of __________________________________________ additional securities of $ ________________ each fully paid arising from the exercise of ____________________ Loan Stocks/Bonds*.
(If they do not rank pari passu, confirm that the certificates have been endorsed accordingly, and provide a specimen copy of the endorsed certificate to the Exchange)
Class of security : ______________________
Total number of issued shares excluding treasury shares | Convertible Loan Stocks/ Bonds* | ||||
Number | $ | Number | $ | ||
Before conversion Add: Issued pursuant to conversion | Before conversion Less: Amount converted | ||||
After conversion | | | Amount outstanding | | |
Outstanding Options: ____________________ additional securities
Name: | Authorised Signature: |
________________________ | _______________ |
Designation: | Date: |
_________________ | _______________ |
Enclosures:
Note: (a) and (b) are not applicable to secondary listing applications.
(d) is not applicable to primary listing applications.
* Delete where applicable.
Appendix 8.4.3 Application for Listing of Securities Arising from Options Exercised Under an Employees' Share Option Scheme — Primary/Secondary* Listing
Cross-referenced from Rules 870(2) and 880
Name of Applicant __________________________________________________
Application for listing of ____________________________ additional securities of $ ___________ each fully paid arising from _____________________ options exercised under the Employees' Share Option Scheme (the "Scheme").
(If they do not rank pari passu, confirm that the certificates have been endorsed accordingly, and provide a specimen copy of the endorsed certificate to the Exchange)
Class of security : ______________________
Total number of issued shares excluding treasury shares | Options granted and outstanding | ||||
Number | $ | Number | $ | ||
Before exercise Add: Issued pursuant to exercise | Before exercise Less: Amount exercised | ||||
After exercise | | | Amount outstanding | | |
Total number and amount of Outstanding Convertible Loan Stock/Bonds*
:$ _________________ (if more than one issue, give a breakdown)
Name: | Authorised Signature: |
________________________ | _______________ |
Designation: | Date: |
_________________ | _______________ |
Enclosures:
Note: (a) and (b) are not applicable to secondary listing applications.
(d) is not applicable to primary listing applications.
* Delete where applicable.
Appendix 8.4.4 Application for Listing and Quotation of Securities to be Issued Pursuant to a Scrip Dividend Scheme — Primary/Secondary* Listing
Cross-referenced from Part IX of Chapter 8
Name of Issuer: ____________________________________________________________
No. of ordinary shares to be listed: _______________________________________________
Shares issued in respect of dividend announced on : __________________________________ Ranking of shares: ____________________________________________________________
(if they do not rank pari passu, confirm that the new certificates have been endorsed accordingly, and provide a specimen copy of the endorsed certificate to the Exchange)
For issuers with a primary listing on SGX
Issue Price: __________________________________________________________________
The shares are issued pursuant to (tick one as appropriate):—
Specific shareholder approval obtained for the adoption of the Scrip Dividend Scheme on [Date of general meeting]; OR
Specific annual shareholder approval obtained for the issue of shares pursuant to the Scrip Dividend Scheme on [Date of general meeting] under Section 161 of the Act; OR
Shareholder approval obtained for the share issue mandate obtained pursuant to Listing Rule 806 on [Date of general meeting].
(a) No. of shares at the time of mandate obtained | |
(b) 20% of (a) [non-pro rata limit applicable under Rule 806] | |
(c) Less: No. of shares previously issued under the mandate | |
(d) Less: No. of shares to be issued for this dividend declared | |
(e) No. of shares available under the mandate (b) – [(c)+(d)] |
The Board of Directors confirms that:—
Enclosures:—
Note:—
Name: ____________________________________
Authorised Signature: ________________________
Designation: _______________________________
Date: _____________________________________
Added on 29 September 201129 September 2011.
Appendix 13.1 Notice of 3 Consecutive Years' Losses
(Cross-referenced from Rule 1312 and Practice Note 13.2)
Name of Issuer:_________________________ hereby gives notice that:
The Company wishes to draw investors' attention to Rule 1311 of the Listing Manual which states that the Exchange will place an issuer on a watch-list if it records pre-tax losses for the 3 most recently completed consecutive financial years (based on audited full year consolidated accounts) and an average daily market capitalisation of less than S$40 million over the last 6 months.
Investors should also note that pursuant to Practice Note 13.2 Paragraph 2.2, the Exchange conducts half-yearly reviews to identify issuers to be included on the watch-list. The half-yearly review will take place on the first market day of June and December of each year. The Company will make an immediate announcement should it be notified by the Exchange that it will be placed on the watch-list.
Amended on 1 March 20161 March 2016 and 1 June 20201 June 2020.